The Wall Street Journal @WSJ
From @WSJopinion: There is no demonstrated need for the Valid Act other than to further enlarge the FDA’s jurisdiction, write Brian Harrison and Bob Charrow. When speed and flexibility are paramount, a large bureaucracy shouldn’t be in charge. https://t.co/uKMzCmyIkT — PolitiTweet.org